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Abstract 
Background: The objective of this study was to establish the quantity and quality of research publications outputs by grant recipients of the Cancer 
Association of South Africa (CANSA) over a 10-year period (1994–2003).
Methods: Peer-reviewed publications in the PubMed database that were related to CANSA grants and were, published between 1994 and 2003 were 
counted per grantee in 2005, and the mean impact factor of all publications for 2005 was obtained from the Institute for Scientific Information (ISI).
Results: Over the 10-year period, 129 different researchers from 10 different institutions conducted 192 projects that yielded 570 relevant peer-
reviewed publications that are recorded in the PubMed database. CANSA grants totalled R28.2 million and the mean impact factor of all the 
publications was 3.8. The number of publications per grantee, over the period analysed, varied considerably, from zero to 79, with 10% of the 
grantees publishing more than 10 (one per year). A significant group of 36% did not publish at all. Most of the studies (64%) concerned aspects of 
cancer biology and therapy, while only 26% of the projects involved issues relating to the prevention, epidemiology and social aspects of cancer.
Conclusions: Because grants from CANSA are partial and do not pay for the major components of most research projects, such as salaries, the 
data obtained here is insufficient to create a benchmark for the cost of an average, peer-reviewed cancer research publication in South Africa. 
Nevertheless, it can be concluded that, on average, a contribution of about R50 000 from CANSA (value from 1994 to 2003) contributed to the 
appearance of one peer-reviewed cancer research publication with an average impact factor of 3.8 in the period under study. The most popular 
subjects of research were cancer biology and treatment. In order to bring about more balance in the future, more attention needs to be focused on 
the prevention, early detection, epidemiology and social aspects of cancer. 
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Introduction
Over the past 30 years, a few members of the South African public have 
made relatively large bequests to the Cancer Association of South Africa 
(CANSA) for the stated purpose of conducting cancer research. CANSA 
has accepted the challenge to be a worthy custodian of these funds, 
which have been appropriately ringfenced and are carefully invested in 
shares for growth by a special Investment Committee of CANSA. Over 
the years, the capital value of these shares has grown extensively and 
CANSA is now in the position to make about R4 to 5 million available 
from dividends and interest for research every year without eroding 
the capital significantly.1 This is a significant amount, because the total 
cancer research funding of the South African Medical Research Council 
does not exceed R10 million per annum.2 Furthermore, this is a significant 
development because it constitutes an independent, nongovernmental 
cancer research funding “engine” in South Africa that should be able to 
be self-sustaining until the cancer problem is substantially solved. 
From 2003 to 2006, CANSA underwent a paradigm shift, with much 
more emphasis being placed on the more social aspects of cancer, such 
as advocacy, palliation, health promotion, early detection and prevention, 
than on the so-called “biomedical” aspects of cancer, i.e. studies on the 
biology of cancer per se and on enhancing the treatment of cancer. This 
policy change is reflected in the CANSA mission, which states – “We 
will substantially reduce the impact of cancer by promoting health in 
all communities within South Africa, through advocacy and sustainable 
facilitation of research, prevention, early detection and care”.1 In 
the light of this change in emphasis, it was of importance to have an 
audit conducted of the past 10 years of research funding in terms of 
publication output and the ranking of different research fields and 
research projects needing advocacy in the future. Such an audit could 
be executed readily, because CANSA does not fund more than about 
50 projects at a time, in comparison to the Medical Research Council 
(MRC) and National Research Foundation (NRF), which support hundreds 
of projects at any time.
Bibliometric studies on cancer research appear to be quite scarce, 
although a few have been published with a wide spectrum of objectives, 
including analysing growth trends for a particular country (India), 
comparisons with other countries, lists of authors with more than 
50 publications, core journals, productive institutions,3 and the absolute 
sum and mean of impact factors of publications on cancer molecular 
epidemiology normalised by country population and gross domestic 
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product.4 There have also been studies on the analysis of research 
productivity in the fields of infectious diseases,5 microbiology,6 
parasitology,7 ophthalmology8 and family medicine.9 
The unique aspect of this study, which was not addressed by the others, 
was the relationship between the quantitative aspects of research grants 
made by a nongovernmental organisation (CANSA) and the research output 
in terms of the absolute number and mean impact factor of publications 
over a 10-year period. A possible reason why most existing studies do not 
contain information on the financial input into cancer research studies 
and only focus on the bibliometric output is that the details of individual 
financial allocations are often kept confidential by the granting body and/
or the host institution. In this unique study, financial input details from 
CANSA were available, as well as the exact nature of the studies, and 
from this information a relationship of the mean financial input relative 
to mean bibliographic output could be ascertained – bearing in mind that 
the bulk of the financial input from the researcher’s institution and other 
sources was unknown. Nevertheless, this relationship, which is reported 
here, has been of practical value when deciding on the allocation of 
research funds in a particular situation and also when anticipating how 
many publications to expect from a given allocation – while also taking 
account of inflation since the study was conducted.
Methods
An Excel database was compiled of all researchers who received 
research grants from CANSA from 1994 to 2003. The database contained 
the name and designation of the principal investigator who applied for 
the funds, the department, institution, title of the registered project and 
the funding per year. In 2004, all of the researchers were contacted for 
lists of publications. These lists were compared to lists containing peer-
reviewed publications recorded in the PubMed database in 2005 and 
in 2006.10 During seven years of the 10-year period, the author acted 
as an independent consultant research co-coordinator for CANSA and 
was aware of each ongoing project. This knowledge subsequently was 
useful to select references from PubMed that had received CANSA 
funding only and to ignore publications by the same author that were not 
partially funded by CANSA or were not relevant to the project registered 
by CANSA for the award. Selection was also informed by the titles of the 
projects, which often were similar to the titles of the publications. It was 
considered unlikely that publications would be forthcoming more than 
three years after the audit period ended 
(2003). A master list of all publications 
was drawn up and double-checked by 
an independent co-worker, leading to 
consensus that there were no instances 
of significant over- or under-recording of 
relevant publications for any researcher. 
All of the publications were grouped 
according to the relevant journals, and the 
same publication cited by more than one 
author was considered as one publication. 
The ISI Impact Factor of each journal for 
2005 was recorded and the mean impact 
factor of all journals was obtained.11
Results
Heterogeneity of output
Over the 10-year period, 129 different researchers from 10 different 
institutions conducted 192 projects, which yielded 570 relevant peer-
reviewed publications that are recorded in the PubMed database. The 
publications appeared in 253 different journals, of which 28 (4.9%) were 
not indexed in the ISI web of knowledge and consequently not counted 
or used to determine the overall impact factor. CANSA grants totalled 
R28.2 million and the mean impact factor of all publications listed in the 
ISI database was 3.8. The top 10 journals and the frequency of articles in 
which the cancer research publications appeared, were: S Afr Med J (39), 
Anticancer Res (21), J Clin Oncol (18), Hepatology (12), Prostaglandins 
Leukot Essent Fatty Acids (10), Cancer Lett (9), Br J Cancer (9), Eur J 
Cancer Prev (8), Oncology (8) and J Med Virol (7). 
The average cost to CANSA for the appearance of a peer-reviewed 
publication was close on R50 000. The number of publications per 
grantee over the period analysed varied considerably, from zero to 79, 
with 10% of grantees publishing more than 10 (one per year), while 
a significant group of 36% did not publish at all. In order to analyse 
this output distribution in more detail, the number of publications per 
researcher was normalised per R100 000, i.e. one publication resulting 
from a grant of R50 000 would be recorded as two publications for 
R100 000, and so on, as shown in Figure 1.
The average for the whole group is 2.18 publications per R100 000. 
However, it can be seen that 46 (36%) of the grant recipients did not 
publish at all (grantees 1 to 46 in Figure 1). The average for the publishing 
group was 6.86 publications per R100 000, and the most prolific 
researcher published 15 publications per R100 000 over the period. In 
absolute terms, this amounted to 79 publications over 10 years.
Portfolio of projects
In order to ascertain the main focus areas, the 192 projects were divided 
into an ascending hierarchy of categories according to the number of 
projects per category, as shown in Table I.
It can be seen from Table I that more than two-thirds of the projects 
concerned cancer biology and therapy (shaded areas), while epidemiology, 
prevention, early detection and the psychosocial aspects of cancer were 
the subjects of only 20% of the projects. 
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Discussion
How good was the output?
The output of 570 publications over 10 years by 129 researchers, 
with a mean journal impact factor of 3.8 at a total cost of R28.2 million 
($4.76 million)12 and an average CANSA grant of R50 000 per publication, 
may seem to be exemplary from a quantitative and qualitative point of 
view. However, there appears to be no mechanism for making value 
judgments, because in every case the CANSA award is an unknown 
fraction of the real total cost of each individual publication. In order to 
make really accurate comparisons, much more data would be needed, 
including a breakdown of the grant budget (salaries, consumables, 
apparatus, travel) per project, as very few CANSA grants include funds for 
assistants or technical personnel. Furthermore, the salary of the principal 
investigator is never paid by CANSA, while NIH grants, for instance, often 
cover this expenditure. 
Nevertheless, some comparative indicators were found. The impact 
factors of oncology publications in oncology journals in the European 
Union for 1999 were 2.4 for publications emanating from the European 
Union (EU) and 3.3 for those from the United States.13 The average 
impact factor of 3.8 for the CANSA grantees compares favourably with 
this. Furthermore, evidence was found of biological publications costing 
between $37 000 and $251 889 in the timeframe when the average 
CANSA grant was about R50 000 (or $8 000).14.15,16 It is concluded from 
this that the international total cost per publication varies widely, but 
is substantially higher than an average CANSA grant, suggesting that 
the grant, which is only a fraction of the total expenditure, appears 
to be a good investment for facilitating the creation of peer-reviewed 
publications in the South African context.
Why did so many not publish? 
As shown in Figure 1, more than a third of the CANSA grantees 
(n = 46, 36%) did not publish anything up to 2005, despite receiving 
CANSA grants totalling R6.2 million ($1.05 million) over 10 years 
(1994–2003). In one case, zero publications were detected after 
3.5 years of funding that totalled over R1 million, and the project was 
stopped forthwith in its fourth year. In most cases it only became clear in 
year 4, after three years of CANSA funding, that no publications were 
forth-coming. The agreement between CANSA and the grantee and 
research institution does not mention any conditions concerning the 
quantity or quality of publications relative to receiving the grant. It has 
always been an implicit belief that the researchers would publish to 
a greater or lesser extent. Analysis of the 46 non-publishing grantees 
yielded some information that could explain why these grantees did 
not publish. In almost every case, there was only one application and 
one project, while the most prolific researchers reapplied for funding 
every three years – for more than a decade in some cases. Because 
they did not have any intention of reapplying for a new cycle of funding, 
non-publication was probably not an issue for the non-publishers. 
Furthermore, CANSA only funds PhD and/or medically qualified principal 
investigators. Exceptions were made to this rule in six cases in which 
investigators without these qualifications were funded, and in each 
case no publications materialised, probably due to inexperience. In 
eight cases the principal investigator abandoned the project for various 
reasons, such as leaving the project, the institution or the country or 
receiving major funding from another source. In three cases there were 
no publications towards the end of the third year and the senior principal 
investigators were given the benefit of the doubt that publications would 
appear during a further cycle of three years, which again yielded nothing. 
Of the remaining 24 investigators, 12 were PhDs and 12 were medically 
qualified. There is no obvious reason why they did not publish. 
Petrak and Bozikov did a thorough analysis of journal publications at 
Zagreb University Medical School from 1995 to 1999.16 They also found 
a high variance in the number of publications on the individual level, with 
15.4% of the faculty at the rank of professor and 45% at assistant rank 
not publishing a single paper in the period analysed. No explanation was 
given. It is clear that the loss of R6.2 million of CANSA research funds 
due to non-publication cannot be tolerated any further. The funds come 
from the public, who expect maximum efficiency in the investment, 
management, application and good governance of the funds. The zero 
productivity of 46 investigators has diluted the sterling performance 
of the other 83 who did publish. In order to try to rectify this situation 
permanently, it has been decided, as policy, that the fourth quarterly 
payment of any three-year grant, which is due in April of the fourth year, 
will not be paid if there is no evidence of a publication or manuscript in 
the final progress report at the end of the third year. 
Criteria for CANSA research funding 
Table I shows that only 16% of projects conducted in the analysed period 
involved the psychosocial aspects of cancer, such as coping with cancer, 
preventive education, epidemiology and health promotion. This low 
level of funding for research on the psychosocial aspects of cancer was 
not due to unfair bias or the irrational rejection of suitable applications 
concerning these subjects. For the past 25 years the CANSA Research 
Committee has selected projects purely on merit and there is no proof 
to the contrary. The low number of psychosocial projects selected was 
due to the low number submitted and/or insufficient merit. South Africa 
Table I: Number of CANSA-funded cancer research projects in different 
categories (1994–2003)
Category No of projects Percentage
1 Cancer biochemistry 43 22
2 Therapy-laboratory studies 24 12
3 Cancer physiology 16 8
4 Prevention-laboratory 16 8
5 Therapy-clinic chemotherapy 15 8
6 New drugs 12 6
7 Therapy-clinic radiotherapy 11 6
8 Epidemiology 11 6
9 Psychosocial aspects: stress 10 5
10 Diagnosis biochemistry 9 5
11 General 7 4
12 Early detection pathology 5 3
13 Psychosocial aspects: perceptions 4 3
14 Psychosocial aspects: quality of life 3 2
15 Therapy-clinic surgery 2 1
16 Prevention-education 2 1
17 Health promotion 1 < 1
18 Prevention-vaccine 1 < 1
Total 192 100
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needs to focus on the early detection and prevention of cancer because 
of the cost-benefit ratio compared to treatment. Excellent projects in 
this direction are urgently needed and young, excellent psychosocial 
researchers should be encouraged to apply. Nevertheless, it should be 
self-evident that, no matter which aspect of cancer is most deserving 
for attention at any moment, in any country, the final decisions should 
concern merit only. In order to obtain an overall picture of the merit 
of the applicant for a research award, there should be documentation 
pertaining to peer-review reports and all substantive PubMed-referenced 
publications, including reviews, editorials, books, chapters and patents, 
impact factors, past funding and the period of past research. This is the 
foundation on which new projects are to be built, looking specifically at 
innovation, feasibility and the overall importance of the project for the 
struggle against cancer in South Africa and the world.
Conclusion
The output of 570 peer-reviewed publications over 10 years (1994 to 
2003), with an average impact factor of 3.8, by 129 researchers who 
had received 192 CANSA grants totalling R28.2 million appears to be 
exemplary in terms of the limited available international indicators.13–16 
However, no information was available to make any direct comparisons 
and value judgments concerning the return on the investment, because 
CANSA grants only pay for a fraction of the research costs, and these 
costs vary from project to project. Nevertheless, a benchmark has been 
established that a R50 000 grant facilitated the appearance of one peer-
reviewed publication in the South African CANSA environment from 1994 
to 2003. This benchmark may only have some measure of relevance 
within the CANSA-related cancer research award environment.
The most popular subjects of research were cancer biology and 
experimental treatment modalities in the laboratory and in the clinic. In 
order to bring about more balance in future between different aspects 
of cancer, more attention and funding needs to be focused on the 
prevention, early detection, epidemiology and social aspects of cancer, 
such as care involving palliation.  
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